SCHEDULE 4Disclosure of information under section 246B of the 2006 Act: prescribed bodies and prescribed purposes
1
1
The bodies specified in column 1 of Table 1, being bodies appearing to the Secretary of State to represent UK producers, are prescribed for the purposes of section 264B(1)(k) of the 2006 Act.
2
The purpose for which a body specified in column 1 of Table 1 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.
Column 1 – Bodies | Column 2 – The purpose for which information disclosed under section 264B(1) of the 2006 Act may be used |
---|---|
Association of British Healthcare Industries; Association of Pharmaceutical Specials Manufacturers; British Association of European Pharmaceutical Distributors; British Generic Manufacturers Association; British Healthcare Trades Association; British In Vitro Diagnostics Association; Healthcare Distribution Association; NHS Pharmacy Production Committee; NHS Pharmaceutical Quality Assurance; Proprietary Association of Great Britain; Surgical Dressings Manufacturers Association Committee; Urology Trade Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (l). |
Association of Independent Multiple Pharmacies; Company Chemists' Association; National Pharmacy Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a) to (k). |
BioIndustry Association; Ethical Medicines Industry Group. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i), (l) and (m). |
Association of the British Pharmaceutical Industry | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c), (e), (g), (i) and (k) to (m). |
British Medical Association; Dispensing Doctor's Association. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(a), (c), (d), (f), (g) and (i) to (k). |
Pharmaceutical Services Negotiating Committee | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(b) and (c). |
2
1
The bodies specified in column 1 of Table 2 are prescribed for the purposes of section 264B(1)(l) of the 2006 Act.
2
The purpose for which a body specified in column 1 of Table 2 may use confidential or commercially sensitive information disclosed to it under section 264B(1) of the 2006 Act is the purpose prescribed in the corresponding entry in column 2 of that Table.
Column 1 – Bodies | Column 2 – Purpose for which information disclosed under section 264B(1) of the 2006 Act may be used |
---|---|
Any NHS foundation trust; Any NHS trust established under the 2006 Act; Any F1integrated care board. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(c). |
Any NHS trust established under the 2006 Wales Act; Any Local Health Board. | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(f). |
Any Health Board constituted under section 2 of the 1978 Act | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(i). |
The Regional Health and Social Care Board established under section 7 of the Health and Social Care (Reform) Act Northern Ireland 2009 M1 | The purpose is that of exercising functions connected with any of the matters specified in section 264A(3)(k). |